๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Re: The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer

โœ Scribed by Dieter Jocham; Christian Doehn


Book ID
113611380
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
112 KB
Volume
55
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Changes in alkaline phosphatase levels i
โœ Fritz H. Schrรถder; Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Neal D. S ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB

Study Type โ€“ Therapy (RCT)โ€จLevel of Evidenceโ€ƒ1b ## OBJECTIVE To compare the activity of degarelix, a new gonadotrophinโ€releasing hormone (GnRH) blocker, with leuprolide depot 7.5โ€ƒmg in the control of total serum alkaline phosphatase (Sโ€ALP) levels in patients with prostate cancer. ## PATIENTS AND